2025-03-27 Using PET Radiopharmaceutical to Predict Advanced MCL Outcomes JNCCN 360 Mantle Cell Lymphoma Using PET Radiopharmaceutical to Predict Outcomes in Advanced Mantle Cell Lymphoma Mantle Cell Lymphoma: Comparing Outcomes With Time-Limited Initial Regimens Relapsed Mantle Cell Lymphoma: Treatment Strategies After CAR T-Cell Therapy JNCCN 360 Ovarian Cancer Genetic Testing in Gynecologic Cancers: Breaking Barriers for Better Patient Care Reproductive Factors and Risk of Epithelial Ovarian Cancer in Asian Women Gottfried E. Konecny, MD, on Targeting Folate Receptor Alpha in Ovarian Cancer JNCCN 360 Chronic Lymphocytic Leukemia Venetoclax/Obinutuzumab May Improve PFS in CLL Warehouse-Based Vaccination Strategy in Patients With CLL: Trial Offers Proof of Concept Acalabrutinib, Venetoclax, and Obinutuzumab: Trio for Treatment-Naive TP53-Aberrant CLL 回上一頁
